Infectious Diseases Research

Scientific Papers

• Cózar A, Ramos-Martínez A, Merino E, Martínez-García C, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Munoz LA, Salavert M, Pérez-Rodríguez MT, García D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez C, Cuquet J, Gil-Campesino H, Torres L, Sánchez-Porto A, Royuela A, Cobo J; Study group. High delayed mortality after the first episode of Clostridium difficile infection. Anaerobe. 2019 Apr 5;57:93-98. doi: 10.1016/j.anaerobe.2019.04.004. [Epub ahead of print] PubMed PMID: 30959165. +Pubmed +DOI
• Guillén Y, Noguera-Julian M, Rivera J, Casadella M, Zevin AS, Rocafort M, Parera M, Rodríguez C, Arumí M, Carrillo J, Mothe B, Estany C, Coll J, Bravo I, Herrero C, Saz J, Sirera G, Torrella A, Navarro J, Crespo M, Negredo E, Brander C, Blanco J, Calle ML, Klatt NR, Clotet B, Paredes R. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 Jan;12(1):232-246. doi: 10.1038/s41385-018-0083-7. Epub 2018 Aug 31. PubMed PMID: 30171206. +Pubmed +DOI
• Pérez-Rodríguez MT, Sousa A, López-Cortés LE, Martínez-Lamas L, Val N, Baroja A, Nodar A, Vasallo F, Álvarez-Fernández M, Crespo M, Rodríguez-Bano J. Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2019 Apr 1;74(4):1101-1107. doi: 10.1093/jac/dky556. PubMed PMID: 30689894 +Pubmed +DOI
• Sousa A, Pérez-Rodríguez MT, Suarez M, Val N, Martínez-Lamas L, Nodar A, Crespo M. Validation of a clinical decision tree to predict if a patient has a bacteraemia due to a ?-lactamase producing organism. Infect Dis (Lond). 2019 Jan;51(1):32-37. doi: 10.1080/23744235.2018.1508883. Epub 2018 Oct 29. PubMed PMID: 30371118. +Pubmed +DOI
• Sousa A, Pérez-Rodríguez MT, Suárez M, Val N, Martínez-Lamas L, Nodar A, Longueira R, Crespo M. Short- versus long-course therapy in gram-negative bacilli bloodstream infections. Eur J Clin Microbiol Infect Dis. 2019 May;38(5):851-857. doi: 10.1007/s10096-019-03467-5. Epub 2019 Jan 24. PubMed PMID: 30680566. +Pubmed +DOI
• Vázquez-Morón S, Berenguer J, González-García J, Jiménez-Sousa MÁ, Canorea I, Guardiola JM, Crespo M, Quereda C, Sanz J, Carrero A, Hontanón V, Avellón A, Resino S. Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014). Sci Rep. 2019 Feb 4;9(1):1143. doi: 10.1038/s41598-018-37328-6. PubMed PMID: 30718554; PubMed Central PMCID: PMC6361883. +Pubmed +DOI

Scientific Papers

• AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Executive summary of the GeSIDA consensus document on control and monitoring of HIV-infected patients. Enferm Infecc Microbiol Clin. 2018 May;(E-PUB) PMID: 29793873. http://www.ncbi.nlm.nih.gov/pubmed/29793873 +Pubmed +DOI
• Carrillo J, Negredo E, Puig J, Molinos-Albert LM, Rodríguez de la Concepción ML, Curriu M, Massanella M, Navarro J, Crespo M, Vinets E, Millá F, Clotet B, Blanco J. Memory B cell dysregulation in HIV-1-infected individuals. AIDS. 2018 Jan;32(2):149-60. PMID: 29112067. http://www.ncbi.nlm.nih.gov/pubmed/29112067 +Pubmed +DOI
• Cobo J, Merino E, Martínez C, Cózar-Llistó A, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Munoz LA, Salavert M, Pérez-Rodríguez MT, García-Rosado D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez-Camacho C, Cuquet J, Pino-Calm B, Torres L, Sánchez-Porto A, Fernández-Félix BM; Nosocomial Infection Study Group. Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score. Int J Antimicrob Agents. 2018 Mar;51(3):393-398. doi: 10.1016/j.ijantimicag.2017.09.010. Epub 2017 Sep 20. PubMed PMID: 28939450. +Pubmed +DOI
• Corredoira J, Miguez E, Mateo LM, Fernández-Rodriguez R, García-Rodriguez JF, Peréz-Gonzalez A, Sanjurjo A, Pulian MV, Rabunal R; GESBOGA. Correlation between Streptococcus bovis bacteremia and density of cows in Galicia, northwest of Spain. Infection. 2018 Nov 29. doi: 10.1007/s15010-018-1254-x. [Epub ahead of print] PubMed PMID: 30498902. +Pubmed +DOI
• Esteban R, Pineda JA, Calleja JL, Casado M, Rodríguez M, Turnes J, Morano Amado LE, Morillas RM, Forns X, Pascasio Acevedo JM, Andrade RJ, Rivero A, Carrión JA, Lens S, Riveiro-Barciela M, McNabb B, Zhang G, Camus G, Stamm LM, Brainard DM, Subramanian GM, Buti M. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis. Gastroenterology. 2018 Jun;155(4):1120-1127.e4. PMID: 29958855. http://www.ncbi.nlm.nih.gov/pubmed/29958855 +Pubmed +DOI
• Martínez Lamas L, Pérez Rodríguez MT, Álvarez Ramos I, Bouza Soage ME, Figueroa Lamas MP, Álvarez Fernández M. Role of Pneumocystis jirovecii in patients with different pulmonary underlying condition using a nested-PCR. Rev Esp Quimioter. 2018 Aug;31(4):336-343. Epub 2018 Jun 29. PubMed PMID: 29956896; PubMed Central PMCID: PMC6172691. +Pubmed
• Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontanón V, Munoz-Fernández MÁ, Resino S; GESIDA 3603b Study Group. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients. AIDS. 2018 Jun 1;32(9):1095-1105. doi: 10.1097/QAD.0000000000001787. PubMed PMID: 29438197. +Pubmed
• Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Munoz A, Casado A, Podzamczer D. Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study. J Antimicrob Chemother. 2018 Aug 1;73(8):2171-2176. doi: 10.1093/jac/dky175. PubMed PMID: 29788066. +Pubmed +DOI
• Papst L, Beovi? B, Pulcini C, Durante-Mangoni E, Rodríguez-Bano J, Kaye KS, Daikos GL, Raka L, Paul M; ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin Microbiol Infect. 2018 Oct;24(10):1070-1076. doi: 10.1016/j.cmi.2018.01.015. Epub 2018 Feb 1. PubMed PMID: 29410094. +Pubmed +DOI
• Pérez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Marino A, Crespo M, Hernández-Quero J, Iribarren JA, Gutiérrez F, Terrón A, Esteban H, Pérez-Molina JA; GESIDA 7011 Study Group members . Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial. J Antimicrob Chemother. 2018 Sep 1;73(9):2444-2451. doi: 10.1093/jac/dky212. PubMed PMID: 29897573. +Pubmed
• Pousada G, Lago-Docampo M, Prado S, Varela-Calvino R, Mantinán B, Valverde D. Functional assessment of the BMPR2 gene in lymphoblastoid cell lines from Graves´ disease patients. J Cell Mol Med. 2018 Mar;22(3):1538-47. PMID: 29266775. http://www.ncbi.nlm.nih.gov/pubmed/29266775 +Pubmed +DOI
• Poveda E, Crespo M. Hot News: Impact of Low-level Viremia on Treatment Outcomes During ART – Is it Time to Revise the Definition of Virological Failure? AIDS Rev. 2018 Jan-Mar;20(1):71-72. PubMed PMID: 29628513. +Pubmed
• Poveda E, Crespo M. Hot News: Impact of Low-level Viremia on Treatment Outcomes During ART – Is it Time to Revise the Definition of Virological Failure? AIDS Rev. 2018 Jan-Mar;20(1):71-72. PubMed PMID: 29628513. +Pubmed
• Poveda E, Crespo M. Hot News: Impact of Low-level Viremia on Treatment Outcomes During ART – Is it Time to Revise the Definition of Virological Failure? AIDS Rev. 2018;20(1):71-2. PMID: 29628513. http://www.ncbi.nlm.nih.gov/pubmed/29628513 +Pubmed
• Sousa A, Pérez-Rodríguez MT, Nodar A, Martínez-Lamas L, Vasallo FJ, Álvarez-Fernández M, Crespo M. Clinical and microbiological characteristics of unusual manifestations of invasive pneumococcal disease. Enferm Infecc Microbiol Clin. 2018 May;36(5):284-9. PMID: 28648390. http://www.ncbi.nlm.nih.gov/pubmed/28648390 +Pubmed +DOI
• Sousa A, Pérez-Rodríguez MT, Soto A, Rodríguez L, Pérez-Landeiro A, Martínez-Lamas L, Nodar A, Crespo M. Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2018 Nov 1;73(11):3170-3175. doi: 10.1093/jac/dky295. PubMed PMID: 30099490. +Pubmed +DOI

Clinical Practice Guidelines

• Documento de consenso de GESIDA sobre control y monitorización de la infección por el VIH, 2018. Disponible en: http://gesida-seimc.org/wp-content/uploads/2018/01/gesida_DC_Control_y_Monitorizacion_b23_01_18.pdf

Scientific Papers

• Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J, GESIDA HIV/HCV Cohort Study Group. Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology. 2017 Aug;66(2):344-56. PMID: 28109003. IF2017: 14.079; D1. http://www.ncbi.nlm.nih.gov/pubmed/28109003 +Pubmed +DOI
• Crespo M, Navarro J, Moreno S, Sanz J, Márquez M, Zamora J, Ocampo A, Iribaren JA, Rivero A, Llibre JM. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group. Enferm Infecc Microbiol Clin. 2017 Oct;35(8):493-8. PMID: 27061975. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27061975 +Pubmed +DOI
• de Mendoza C, Caballero E, Aguilera A, Requena S, de Lejarazu RO, Pirón M, González R, Jiménez A, Roc L, Trevino A, Benito R, Fernández-Alonso M, Aguinaga A, Rodríguez C, García-Costa J, Blanco L, Ramos JM, Calderón E, Eirós JM, Sauleda S, Barreiro P, Soriano V, Spanish HTLV Network (Morano L; Pérez-Castro S; Poveda E). Human T-lymphotropic virus type 1 infection and disease in Spain. AIDS. 2017 Jul;31(12):1653-63. PMID: 28700391. IF2017: 4.914; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28700391 +Pubmed +DOI
• Grau-Expósito J, Serra-Peinado C, Miguel L, Navarro J, Curran A, Burgos J, Ocana I, Ribera E, Torrella A, Planas B, Badía R, Castellví J, Falcó V, Crespo M, Buzon MJ. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. Prasad VR (ed.). MBio. 2017 Sep;8(4):e00876-17. PMID: 28698276. IF2017: 6.689; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28698276 +Pubmed +DOI
• Iribarren Díaz M, Ocampo Hermida A, González-Carreró Fojón J, Longueira Suárez R, Rivera Gallego A, Casal Núnez E, Ocampo Álvarez A, Cachay ER. Preliminary results of a screening program for anal cancer and its precursors for HIV-infected men who have sex with men in Vigo-Spain. Rev Esp Enferm Dig. 2017 Apr;109(4):242-9. PMID: 28229612. IF2017: 1.632; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28229612 +Pubmed +DOI
• Lopez Diez E, Perez S, Inarrea A, de la Orden A, Castro MM, Almuster S, Tortolero L, Rodriguez M, Montero R, Ojea A, López Diez E, Pérez S, Inarrea A, de la Orden A, Castro MM, Almuster S, Tortolero L, Rodríguez M, Montero R, Ojea A. Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions. Enferm Infecc Microbiol Clin. 2017 May;35(5):273-7. PMID: 27004428. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27004428 +Pubmed +DOI
• Mateos-Lindemann ML, Pérez-Castro S, Rodríguez-Iglesias M, Pérez-Gracia MT. Microbiological diagnosis of human papilloma virus infection. Enferm Infecc Microbiol Clin. 2017 Nov;35(9):593-602. PMID: 27353835. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27353835 +Pubmed +DOI
• Moreno S, Antela A, García F, Del Amo J, Boix V, Coll P, Fortuny C, Sirvent JLG, Gutiérrez F, Iribarren JA, Llibre JM, Quirós JCLB de, Losa JE, Lozano A, Meulbroek M, Olalla J, Pujol F, Pulido F, Crespo Casal M, García JG, Aldeguer JL, Molina JAP, Podzamczer Palter D, Román AR, Grupo Redactor de GESIDA/SEIMC. Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016. Enferm Infecc Microbiol Clin. 2017 Jun;35(6):377-83. PMID: 28236498. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28236498 +Pubmed +DOI
• Navarro J, Laguno M, Vilchez HH, Guardiola JM, Carrion JA, Force L, Cairó M, Cifuentes C, Vilaró J, Cucurull J, Marco A, Roget M, Erice E, Crespo M, Catalano-Balear Study Group. Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients. J Antimicrob Chemother. 2017 Oct;72(10):2850-6. PMID: 29091196. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/29091196 +Pubmed +DOI
• Pernas B, Rego-Pérez I, Tabernilla A, Balboa V, Relano S, Grandal M, Crespo M, Mena Á, Castro-Iglesias Á, Blanco FJ, Poveda E. Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication. J Antimicrob Chemother. 2017 Nov;72(11):3159-62. PMID: 28961892. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/28961892 +Pubmed +DOI
• Poveda E, Crespo M. When is Early Antiretroviral Therapy Early Enough for HIV Remission? AIDS Rev. 2017 Apr;19(2):113-4. PMID: 28534887. IF2017: 2.775; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28534887 +Pubmed
• Poveda E, Puoti M, García-Deltoro M, Pineda JA, Téllez F, Granados R, Morano L, García F, Grupo de Estudio de Hepatitis Víricas (GEHEP). News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference. AIDS Rev. 2017 Jan;19(1):47-53. PMID: 28182613. IF2017: 2.775; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28182613 +Pubmed
• Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, Gatell JM. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):88-99. PMID: 27459919. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27459919 +Pubmed +DOI
• Rodríguez-Da Silva A, Miralles C, Ocampo A, Valverde D. [Prevalence study of the genetic markers associated with slow progression of human inmunodefiency virus type 1 in the Galician population (Northwest of Spain)]. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):104-7. PMID: 26100217. IF2017: 1.707; Q3; JCR-CAT: MICROBIOLOGY. http://www.ncbi.nlm.nih.gov/pubmed/26100217 +Pubmed +DOI
• Rodríguez-Osorio I, Cid P, Morano L, Castro Á, Suárez M, Delgado M, Margusino L, Meijide H, Pernas B, Tabernilla A, Pedreira JD, Mena Á, Poveda E. Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients. J Clin Virol. 2017 Mar;88:58-61. PMID: 28183063. IF2017: 3.101; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28183063 +Pubmed +DOI
• Serrano-Villar S, Hernández-Novoa B, de Benito A, Del Romero J, Ocampo A, Blanco JR, Masiá M, Sendagorta E, Sanz G, Moreno S, Pérez-Molina JA. Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM. Grce M (ed.). PLoS One. 2017 Nov;12(11):e0188851. PMID: 29190817. IF2017: 2.766; Q1. http://www.ncbi.nlm.nih.gov/pubmed/29190817 +Pubmed +DOI
• Sousa Dominguez A, Perez-Rodríguez MT, Nodar A, Martinez-Lamas L, Perez-Landeiro A, Crespo Casal M. Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam. J Antimicrob Chemother. 2017 Dec;72(4):1262-3. PMID: 27999042. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/27999042 +Pubmed +DOI

Clinical Practice Guidelines

• Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana, 2016 Disponible en: http://gesida-seimc.org/wp-content/uploads/2017/02/gesida-guiasclinicas-2016-tar.pdf
• Guías AEEH/SEIMC de manejo de la Hepatitis C, 2017 Disponible en: http://aeeh.es/wp-content/uploads/2017/03/documento-consenso.pdf

Scientific Papers

• Blanco-Pérez JJ, Pérez González A, Morano Amado LE, Guerra Vales JL, Vázquez Gallardo R, Salgado Barreira Á, Cruz Carmona MJ, González Barcala FJ. Clinical Significance of Environmental Mycobacteria Isolated From Respiratory Specimens of Patients With and Without Silicosis. Arch Bronconeumol. 2016 Mar;52(3):145-50. PMID: 26304492. IF2016: 2.979; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26304492 +Pubmed +DOI
• Ferenci P, Caruntu FA, Lengyel G, Messinger D, Bakalos G, Flisiak R, TriCo, Study Group (L MORANO). Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial. Infect Dis Ther. 2016 Jun;5(2):113-24. PMID: 27228998. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27228998 +Pubmed +DOI
• Fernández-García A, Delgado E, Cuevas MT, Vega Y, Montero V, Sánchez M, Carrera C, López-Álvarez MJ, Miralles C, Pérez-Castro S, Cilla G, Hinojosa C, Pérez-Álvarez L, Thomson MM. Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain. PLoS One. 2016;11(2):e0148549. PMID: 26900693. IF2016: 2.806; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26900693 +Pubmed +DOI
• Geskus RB, González C, Torres M, Del Romero J, Viciana P, Masiá M, Blanco JR, Iribarren M, De Sanjosé S, Hernández-Novoa B, Ortiz M, Del Amo J, CoRIS-HPV Study Group. Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors. AIDS. 2016 Jan;30(1):37-44. PMID: 26355673. IF2016: 5.003; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26355673 +Pubmed +DOI
• Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Munoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee. Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enferm Infecc Microbiol Clin. 2016 Oct;34(8):517-23. PMID: 27056581. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27056581 +Pubmed +DOI
• Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Munoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enferm Infecc Microbiol Clin. 2016 Oct;34(8):516.e1-516.e18. PMID: 26976381. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26976381 +Pubmed +DOI
• Jensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourliere M, Hassanein T, Nishiguchi S, Kao J-H, Omata M, Paik SW, Wong DK, Tam E, Kaita K, Feinman SV, Stern JO, Scherer J, Quinson A-M, Voss F, Gallivan J-P, Böcher WO, Ferenci P. Faldaprevir, pegylated interferon, and ribavirin for treatment-naive HCV genotype-1: pooled analysis of two phase 3 trials. Ann Hepatol. 2016 Apr;15(3):333-49. PMID: 27049487. IF2016: 1.678; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27049487 +Pubmed +DOI
• Marcellin P, Ahn SH, Chuang W-L, Hui AJ, Tabak F, Mehta R, Petersen J, Lee C-M, Ma X, Caruntu FA, Tak WY, Elkhashab M, Lin L, Wu G, Martins EB, Charuworn P, Yee LJ, Lim SG, Foster GR, Fung S, Morano L, Samuel D, Agarwal K, Idilman R, Strasser SI, Buti M, Gaeta GB, Papatheodoridis G, Flisiak R, Chan HLY. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B. Aliment Pharmacol Ther. 2016 Nov;44(9):957-66. PMID: 27629859. IF2016: 7.286; D1. http://www.ncbi.nlm.nih.gov/pubmed/27629859 +Pubmed +DOI
• Márquez A, Fernández-Aranguren T, Witte T, González-Gay MA, Martín J, Spanish GCA Group, Spanish Scleroderma Group (Mayka Freire; Adrián Sousa). LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition. Clin Exp Rheumatol. 2016;34 Suppl 1(5):208-9. PMID: 27462831. IF2016: 2.634; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27462831 +Pubmed
• Pérez Parente D, Suárez Santamaría M, Suárez Ordónez S, Morano Amado LE. Pulmonary sarcoidosis in the context of a telaprevir-based triple therapy for hepatitis C. Rev Port Pneumol. 2016 Jan;22(1):57-9. PMID: 26422338. IF2016: 1.560; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26422338 +Pubmed +DOI
• Poveda E, Crespo M. New Strategies for a Comprehensive Fight Against HIV Infection using Monoclonal Antibody Therapy. AIDS Rev. 2016 Jul;18(3):166. PMID: 27721508. IF2016: 3.195; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27721508 +Pubmed
• Riera M, Esteban H, Suarez I, Palacios R, Lozano F, Blanco JR, Valencia E, Ocampo A, Amador C, Frontera G, vonWichmann-de Miguel MA, GESIDA Study Group of the HIV quality indicators. [Validation and adhesion to GESIDA quality indicators in patients with HIV infection]. Enferm Infecc Microbiol Clin. 2016 Jun;34(6):346-52. PMID: 26530224. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26530224 +Pubmed +DOI
• Rojas J, Lonca M, Imaz A, Estrada V, Asensi V, Miralles C, Domingo P, Montero M, del Rio L, Fontdevila J, Perez I, Cruceta A, Gatell JM, Arnedo M, Martínez E. Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir. HIV Med. 2016 May;17(5):340-9. PMID: 27089862. IF2016: 3.257; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27089862 +Pubmed +DOI
• Serrano-Villar S, Gutiérrez F, Miralles C, Berenguer J, Rivero A, Martínez E, Moreno S. Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions. Open forum Infect Dis. 2016 Apr;3(2):ofw097. PMID: 27419169. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27419169 +Pubmed +DOI
• Vega Y, Delgado E, de la Barrera J, Carrera C, Zaballos Á, Cuesta I, Marino A, Ocampo A, Miralles C, Pérez-Castro S, Álvarez H, López-Miragaya I, García-Bodas E, Díez-Fuertes F, Thomson MM. Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes. Buratti E (ed.). PLoS One. 2016 Jun;11(6):e0158525. PMID: 27355361. IF2016: 2.806; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27355361 +Pubmed +DOI
• Viciana P, Ocampo A, Hevia H, Palazuelos M, Ledesma F. Sociodemographic and clinical factors associated with the preference between NNRTIs and PIs for the initial treatment of HIV infection: Perfil-es study. AIDS Care. 2016 Oct;28(10):1321-6. PMID: 27140483. IF2016: 1.824; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27140483 +Pubmed +DOI

Book Chapters

• Infecciones causadas por el virus del herpes simple y de la varicela-Zóster.. II – Capítulo 287, pp. 2313 – 2316. MEDICINA INTERNA. Farreras-Rozman (XVIII edición). Cataluna (Espana): Elsevier, 2016. ISBN 978-84-9022-995-8

Scientific Papers

• Álvarez-Argüelles ME, de Ona-Navarro M, Rojo-Alba S, Torrens-Muns M, Junquera-Llaneza ML, Antonio-Boga J, Pérez-Castro S, Melón-García S. Quantification of human papilloma virus (HPV) DNA using the Cobas 4800 system in women with and without pathological alterations attributable to the virus. J Virol Methods. 2015 Sep;222:95-102. PMID: 26057221. IF2015: 1.508; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26057221 +Pubmed +DOI
• Delgado E, Cuevas MT, Domínguez F, Vega Y, Cabello M, Fernández-García A, Pérez-Losada M, Castro MÁ, Montero V, Sánchez M, Marino A, Álvarez H, Ordónez P, Ocampo A, Miralles C, Pérez-Castro S, López-Álvarez MJ, Rodríguez R, Trigo M, Diz-Arén J, Hinojosa C, Bachiller P, Hernáez-Crespo S, Cisterna R, Garduno E, Pérez-Álvarez L, Thomson MM. Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe. PLoS One. 2015 Nov;10(11):e0143325. PMID: 26599410. IF2015: 3.057; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26599410 +Pubmed +DOI
• Pérez-Rodríguez MT, Sousa A, Martínez-Cueto P, Ocampo-Hermida A. HIV encephalitis related to the development of a discordant resistant virus in CNS. Clin Microbiol Infect. 2015 Aug;21(8):e59-60. PMID: 25980354. IF2015: 4.575; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25980354 +Pubmed +DOI
• Poveda E, Wyles D, Morano L, Pineda JA, García F, Grupo de Estudio de Hepatitis Víricas (GEHEP), E P, D W, L M, JA P, F G, GEHEP. News on HIV-HCV coinfection: Update from the 2015 GEHEP conference. AIDS Rev. 2015 Oct;17(4):231-7. PMID: 26616846. IF2015: 2.068; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26616846 +Pubmed

Scientific Papers

• Feijoo J, Eirea M, Limeres J, Abeleira M, Ramos I, Ocampo A, Diz P. HCV clearance from saliva of HIV-HCV-coinfected patients on treatment with interferon plus ribavirin. Oral Dis. 2014 Apr;20(3):313-8. PMID: 23607445. IF: 2.427; Q1. http://www.ncbi.nlm.nih.gov/pubmed/23607445 +Pubmed +DOI
• Garcia F, Poveda E, Pérez-Elías MJ, Quero JH, Ribas MA, Martínez-Madrid OJ, Flores J, Crespo M, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestarán A, Paredes R. Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study. J Int AIDS Soc. 2014 Jan;17(4 Suppl 3):19520. PMID: 25394029. IF: 5.090; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25394029 +Pubmed +DOI
• Martínez E, Jódar Gimeno E, Reyes García R, Carpintero P, Casado JL, Del Pino Montes J, Domingo Pedrol P, Estrada V, Maalouf J, Negredo E, Ocampo A, Munoz-Torres M, Grupo de Estudio de Sida, Sociedad Espanola de Endocrinología y Nutrición, Sociedad Espanola de Investigación Ósea y del Metabolismo Mineral, Sociedad Espanola de Fractura Osteoporótica. [Consensus statement: recommendations for the management of metabolic bone disease in human immunodeficiency virus patients]. Enferm Infecc Microbiol Clin. 2014 Apr;32(4):250-8. PMID: 24332711. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24332711 +Pubmed +DOI
• Pérez-Castro S, Lorenzo-Mahía Y, Inarrea Fernández A, Lamas-González MJ, Sarán-Díez MT, Rubio-Alarcón J, Reboredo-Reboredo MC, Mosteiro-Lobato S, López-Miragaya I, Torres-Pinón J, Melón-García S. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact. Enfermedades Infecc y Microbiol cli?nica. 2014 Oct;32(8):479-85. PMID: 24274937. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24274937 +Pubmed +DOI
• Podzamczer D, Imaz A, Perez I, Viciana P, Valencia E, Curto J, Martín T, Castano M, Rojas J, Espinosa N, Moreno V, Asensi V, Iribarren JA, Clotet B, Force L, Bachiller P, Knobel H, López Bernaldo De Quirós JC, Blanco JR, Rozas N, Vergas J, Ocampo A, Camacho A, Flores J, Gomez-Sirvent JL, KIDAR Study Group. Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients. J Antimicrob Chemother. 2014 Sep;69(9):2536-40. PMID: 24833755. IF: 5.313; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24833755 +Pubmed +DOI
• Podzamczer D, Rozas N, Domingo P, Ocampo A, Van den Eynde E, Deig E, Vergara A, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Munoz J, Fernandez P, Geijo P, de Castro ER, Diz J, Casado A, Torres C. ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study. J Int AIDS Soc. 2014 Jan;17(4 Suppl 3):19814. PMID: 25397558. IF: 5.090; Q1. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4225323&tool=pmcentrez&rendertype=abstract +Pubmed
• Viciana P, Ocampo A, Hevia H, Palazuelos M, Ledesma F. [Initial antiretroviral treatment in human immunodeficiency virus-infected patients in Spain: Decisions made in relation to particular immunovirological characteristics (PERFIL-es study)]. Enferm Infecc Microbiol Clin. 2014 Mar;32(2):93-5. PMID: 24144784. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24144784 +Pubmed +DOI